U.S. markets close in 5 hours 32 minutes
  • S&P 500

    3,295.83
    +24.80 (+0.76%)
     
  • Dow 30

    26,589.63
    +69.68 (+0.26%)
     
  • Nasdaq

    11,130.81
    +125.94 (+1.14%)
     
  • Russell 2000

    1,540.57
    -2.71 (-0.18%)
     
  • Crude Oil

    35.74
    -1.65 (-4.41%)
     
  • Gold

    1,871.80
    -7.40 (-0.39%)
     
  • Silver

    23.23
    -0.13 (-0.55%)
     
  • EUR/USD

    1.1680
    -0.0070 (-0.60%)
     
  • 10-Yr Bond

    0.7840
    +0.0030 (+0.38%)
     
  • GBP/USD

    1.2926
    -0.0061 (-0.47%)
     
  • USD/JPY

    104.4400
    +0.1390 (+0.13%)
     
  • BTC-USD

    13,322.43
    +159.04 (+1.21%)
     
  • CMC Crypto 200

    262.94
    +20.26 (+8.35%)
     
  • FTSE 100

    5,578.25
    -4.55 (-0.08%)
     
  • Nikkei 225

    23,331.94
    -86.57 (-0.37%)
     

Weekly CFO Sells Highlight

GuruFocus.com
·4 mins read

According to GuruFocus Insider Data, the recent CFO sells were for Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Zoetis Inc. (NYSE:ZTS) and Zoom Video Communications Inc. (NASDAQ:ZM).

Regeneron Pharmaceuticals Inc. Executive Vice President Finance CFO Robert E. Landry sold 414 shares

Executive Vice President Finance CFO Robert E. Landry sold 414 shares for $452.49 per share on Feb. 26. Since then, the stock price has increased by 2.89%.


Regeneron Pharmaceuticals Inc. has a market cap of $51.22 billion and its shares were traded around $465.55. The company has a price-earnings ratio of 25.22 and price-sales ratio of 6.77. Over the past five years, Regeneron Pharmaceuticals Inc had an annual average earnings growth of 26.80%.

Regeneron Pharmaceuticals announced its fourth-quarter results with revenue of $2.17 billion and gross profit of $1.95 billion, while the net income was $792 million. The gross profit was $6.28 billion, a 15% increase from the year prior. The net income was $2.44 billion.

President and Chief Scientific Officer George Yancopoulos sold 117,815 shares for $470.47 per share on March 10. Since then, the stock price has decreased by 1.05%.

10% Owner Sanofi sold 128,914 shares for $489.65 per share on March 9. Since then, the stock price has decreased by 4.92%.

Director Joseph L. Goldstein sold 2,000 shares for $475.84 per share on March 9. Since then, the stock price has decreased by 2.16%.

Zoetis Inc. CFO Glenn David sold 43,778 shares

CFO Glenn David sold 43,778 shares for $140.89 per share on March 5. Since then, the stock price has decreased by 10.94%.

Zoetis Inc. has a market cap of $59.59 billion and its shares were traded around $125.48. The company has a price-earnings ratio of 40.20 and price-sales ratio of 9.66. The trailing 12-month dividend yield of Zoetis Inc. stocks is 0.54%, while the forward dividend yield is 0.67%. Over the past 10 years, Zoetis Inc. had an annual average earnings growth of 53.30%. GuruFocus rated Zoetis Inc. the business predictability rank of 2.5-star.

Zoetis Inc. announced its fourth-quarter results with revenue of $1.67 billion and gross profit of $1.14 billion, while the net income was $384 million. The 2019 total revenue was $6.26 billion, a 7% increase from 2018. The gross profit was $4.27 billion, a 9% increase from the year prior. The net income was $1.50 billion.

CEO Kristin C. Peck sold 11,925 shares for $138.1 per share on Feb. 25. Since then, the stock price has decreased by 9.14%.

Director Juan Ramon Alaix sold 263,660 shares for $141.26 per share on March 4. Since then, the stock price has decreased by 11.17%.

Executive Vice President Heidi C. Chen sold 1,179 shares for $134.3 per share on March 2. Since then, the stock price has decreased by 6.57%.

Zoom Video Communications Inc. CFO Kelly Steckelberg sold 11,067 shares

CFO Kelly Steckelberg sold 11,067 shares for $102.66 per share on Feb. 19. Since then, the stock price has increased by 4.69%.

Zoom Video Communications Inc. has a market cap of $29.7 billion and its shares were traded around $107.47. The company has a price-earnings ratio of 1074.70 and price-sales ratio of 41.25.

Zoom Video Communications announced its first-quarter results with revenue of $188.25 million and gross profit of $155.70 million, while the net income was $15.34 million. The 2019 total revenue was $622.66 million, an 88% increase from 2018. The gross profit was $507.26 million, an 88% increase from the year prior. The net income was $25.31 million.

CEO, 10% Owner Eric S. Yuan sold 140,286 shares for $89.17 per share on Feb. 13. Since then, the stock price has increased by 20.52%.

Director Santiago Subotovsky sold 73,168 shares for $108.63 per share on March 10. Since then, the stock price has decreased by 1.07%.

Chief Marketing Officer Janine Pelosi sold 31,850 shares for $107.92 per share on March 9. Since then, the stock price has decreased by 0.42%.

Disclosure: none

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here


This article first appeared on GuruFocus.